1.Meta-analysis of insertion/deletion genetic variation of ACE gene and onset riskof type 2 diabetic nephropathy in Chinese population
Chunhua BEI ; Ying ZHANG ; Linyuan QIN ; Lin YANG ; Jieying DUAN ; Nian LIU ; Hongping YU ; Xiangyuan YU
Chongqing Medicine 2017;46(24):3362-3365
Objective To systematically assess the relation between angiotensin-I converting enzyme(ACE) gene insertion/deletion (I/D) variation and type 2 diabetic nephropathy (T2DN) onset risk among Chinese population.Methods The related literatures were retrieved from the China National Knowledge Infrastructure (CNKI) and Wanfang Data until June 1st,2016.The RevMan 5.0 was used to conduct the statistical analysis.The merge OR value and corresponding 95% confidence interval(95%CI) were used to assess ACE gene I/D polymorphism and T2DN onset risk.Results Totally 29 papers with 4 357 subjects were included according to the inclusion and exclusion standard,including 2 208 cases of DN and 2 149 cases of T2DM without DN.Meta analysis showed that compared with ACE gene I/D polymorphism I allele,D allele could significantly increase the risk of T2DM patients suffering from DN,the OR value and corresponding 95%CI were 1.44(1.25,1.66);the gene analysis showed that ACE gene I/D polymorphism loci were significantly correlated with DN onset risk in the Asian population.The corresponding relative onset risk OR and 95%CI were 1.42(1.15,1.76) and 1.75(1.46,2.10) in the dominant and recessive genetic model.The Begg′s test showed that the included data had no obvious publication bias existence.Conclusion ACE gene I/D polymorphism is closely correlated with the onset risk of T2DN,and D allele might be a risk genetic factor for DN occurrence in the patients with T2DM.
2.Study on degradation performance of star-shaped polymer of ESO and lactide.
Bei ZHANG ; Fu CHUNHUA ; Wang YUANLIANG
Journal of Biomedical Engineering 2011;28(3):517-542
Star-shaped polymer of epoxidized soybean oil (ESO) and lactide is a new material. Its degradation function has an importance to its applications. There are many factors affecting its degradation. This paper is mainly aimed at investigation in which the surface morphology, pH, molecular weight and weight loss rate, branching ESO-lactide star polymers the degree of change were studied. It was found through the experiments that, the changing rates of the branching ESO-lactide star polymers were slower than the degree of PDLLA change compared to the surface morphology, pH, molecular weight and weight loss rate. This has a guiding significance to the further application of ESO-lactide.
Polyesters
;
chemistry
;
Polymers
;
chemistry
;
Soybean Oil
;
chemistry
3.Metaphorical Cognitive Analysis of the Experience of Traditional Chinese Medicine Doctors in Treating Diabetes Mellitus
World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(9):1498-1501
In the context of cognitive science,taking "diabetes mellitus" as an example,through sorting out and analyzing the treatment experience of Ren Jixue,Yan Dexin,and Lv Renhe,to explore the etiology and pathogenesis of its metaphysical characteristics and the cognitive roots of different governance.The experience of three doctors in the treatment of diabetes mellitus is based on the "natural fire","no firewood at the end of the cauldron","hub adverse" and other source domain construction;the unique experience of the physician formed different cognitive structures,resulting in the diversity of the origin of the conceptual metaphor of diabetes mellitus,and thus the diversity of metaphorical cognition of "diabetes mellitus".
4.Research progress on strategies to improve patients′ adherence to anticoagulation with warfarin after mechanical heart- valve replacement
Chunhua HUANG ; Bei XUE ; Xiaorui LIU
Chinese Journal of Practical Nursing 2017;33(25):1996-1999
It is reviewed in this article that the current situation of patients′ adherence to anticoagulation with warfarin after mechanical heart-valve replacement and the measures to improve the situation. Now the adherence situation of the patients is not satisfying to some extent. There are many things we can do to improve the adherence of patients and get a better anticoagulant effect, such as enhancing the health education according to the different background of patients, strengthening the social and psychological support, carrying out effective follow-up and information communication with the patients, the use of the medicine branch box, importing the foreign managing model of self-test and self-manage, expanding the special outpatient service for anticoagulation instruction. We may get a better adherence of anticoagulation with warfarin and improve the prognosis of patients.
5.Identification of a novel mutation of UPB1 gene in a Chinese family affected with beta-ureidopropinoase deficiency.
Jianbo SHU ; Bei SUN ; Chao WANG ; Rui PAN ; Yingtao MENG ; Chunhua ZHANG ; Chunquan CAI ; Shuxiang LIN ; Yuqin ZHANG
Chinese Journal of Medical Genetics 2018;35(6):824-827
OBJECTIVE:
To explore the molecular etiology for a Chinese family affected with beta-ureidopropinoase deficiency.
METHODS:
Genomic DNA was extracted from the peripheral blood samples of family members. All exons and flanking intron regions of the UPB1 gene were amplified by PCR and detected by direct sequencing. The pathogenicity of identified mutation was analyzed using Polyphen2 and SIFT software.
RESULTS:
Compound heterozygous mutations of the UPB1 gene, including c.853G>A (p.A285T) and c.917-1G>A, were discovered in the proband, which were inherited respectively from his mother and father. Bioinformatics analysis suggested that this novel mutation was damaging.
CONCLUSION
The compound heterozygous mutations of the UPB1 gene probably underlie the beta-ureidopropinoase deficiency in the infant. Discovery of c.853G>A also enriched the mutation spectrum of the UPB1 gene.
Abnormalities, Multiple
;
genetics
;
Amidohydrolases
;
deficiency
;
genetics
;
Asian Continental Ancestry Group
;
Brain Diseases
;
genetics
;
China
;
Exons
;
Humans
;
Infant
;
Introns
;
Movement Disorders
;
genetics
;
Mutation
;
Pedigree
;
Purine-Pyrimidine Metabolism, Inborn Errors
;
genetics
7.Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies.
Zhenan DENG ; Meiling JIN ; Changxing OU ; Wei JIANG ; Jianping ZHAO ; Xiaoxia LIU ; Shenghua SUN ; Huaping TANG ; Bei HE ; Shaoxi CAI ; Ping CHEN ; Penghui WU ; Yujing LIU ; Jian KANG ; Yunhui ZHANG ; Mao HUANG ; Jinfu XU ; Kewu HUANG ; Qiang LI ; Xiangyan ZHANG ; Xiuhua FU ; Changzheng WANG ; Huahao SHEN ; Lei ZHU ; Guochao SHI ; Zhongmin QIU ; Zhongguang WEN ; Xiaoyang WEI ; Wei GU ; Chunhua WEI ; Guangfa WANG ; Ping CHEN ; Lixin XIE ; Jiangtao LIN ; Yuling TANG ; Zhihai HAN ; Kian Fan CHUNG ; Qingling ZHANG ; Nanshan ZHONG
Chinese Medical Journal 2023;136(2):230-232